[ad_1] Krystal Biotech’s Jeune reports promising phase 1 data on wrinkles drug [ad_2] Source: (*1*)
Browsing: Healthcare
[ad_1] FDA accepts SpringWorks’ application for mirdametinib for NF1-PN [ad_2] Source: Seekingalpha
[ad_1] Pfizer in collaboration with Quotient Therapeutics for CV, kidney disease therapies [ad_2] Source: Seekingalpha
[ad_1] Virax stock rallies 22% on mpox detection kit deal [ad_2] Source: Seekingalpha
[ad_1] Liquidia requests preliminary injunction against FDA for Tyvaso 3-year exclusivity [ad_2] Source: Seekingalpha
[ad_1] US House committee sends warning letters to CVS, Cigna, UnitedHealth [ad_2] Source: Seekingalpha
[ad_1] Marijuana rescheduling unlikely to lead to cannabis banking reform [ad_2] Source: Seekingalpha
[ad_1] LivaNova rises following possible CMS reimbursement boost for vagus nerve stimulation [ad_2] Source: Seekingalpha
(*3*) Palatin stock climbs 8% on Phase 3 testing update for PL9643 [ad_2] Source: Seekingalpha
[ad_1] Roth starts CG Oncology at purchase, cites anticipated FDA filing [ad_2] Source: Seekingalpha
